IFFE FUTURA Signs a 20,000,000 Euros Equity Commitment with LDA CAPITAL
IFFE FUTURA (MAD:IFF), an industrial and services group based in Oleiros (Galicia, Spain) and listed on BME GROWTH (before the Alternative Equity Market), has signed a 20 million euros equity commitment with the global alternative investment firm LDA Capital.
The Group's balance sheet reached 45.7 million euros in the first half of 2020, mainly after the capital increase carried out in January of the same year, and the positive results of 0.5 million euros accumulated as of June 30, 2020.
David Carro, president and CEO of the group stated: “The support of LDA Capital with the 20 million euros equity commitment represents the endorsement of the strategic plan of our group and provides fundamental support for the future”.
Warren Baker, Managing Partner of LDA Capital, commented, “we are pleased with IFFE FUTURA's trust in LDA Capital as a partner offering flexible financing solutions to support the Company’s growth during this volatile and uncertain business environment.
About IFFE FUTURA
IFFE FUTURA is the parent company of an industrial and services group whose strategic vision consists of forming an innovation ecosystem that educates talent, trains it by valuing third-party projects, and incubates them in the form of its own or participated projects that accelerates until its exit or its conformation as an autonomous business area of the group.
About LDA CAPITAL
LDA Capital is a global investment group with expertise in complex, cross border transactions worldwide. Our team has dedicated their careers to international & cross border opportunities having collectively executed over 200 transactions in both the public and private markets across 42 countries with aggregate transaction values of over US$10 billion.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201104005394/en/
Contact information
MEDIA:
IFFE Futura, s.a.
DAVID CARRO / ANA ROZAS
+34 881.89.60.49 / inversores@iffefutura.es
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SentinelOne is the Only Vendor to Score Highest Across All Three Gartner Critical Capabilities Use Cases11.5.2021 18:40:00 EEST | Press release
SentinelOne, the autonomous cybersecurity platform company, today announced that Gartner has positioned SentinelOne with the highest scores in all three use cases; Type A, B, & C in Gartner’s 2021 Critical Capabilities for Endpoint Protection Platforms report1. Out of the 19 vendors included in the report, SentinelOne is the only vendor that received the highest score across all three Critical Capabilities use cases: Customer use case Type A is focused on “lean forward” organizations that adopt new technologies very early in the adoption cycle. Customer use case Type B is focused on “overall value” by weighing the risks of the early use of new technology against the benefits. Customer use case Type C represents organizations that typically view technology as an expense or operational necessity and use it as a means to reduce costs. “We believe receiving the highest product score across all three customer use cases in the 2021 Critical Capabilities for Endpoint Protection Platforms vali
1E Challenges DEM Market to Deliver More, Launching New Unified eXperience Management Category11.5.2021 17:35:00 EEST | Press release
1E , innovators in endpoint management, today announced Unified eXperience Management (UXM) , a new category that seeks to address the siloed approach inherent in tools in the Digital Experience Monitoring (DEM) space. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210511005842/en/ 1E Tachyon Platform: Unified eXperience Management to improve the Digital Experience of all employees (Graphic: Business Wire) Due to the relative immaturity of the Digital Experience Management category, most tooling is focused on identifying and reporting on the scale of the problem, scoring, and issue identification. These tools create analytics silos that give insight, but are uncoupled from the automation technology that can actually improve end-user experience at an enterprise scale. Meanwhile, employees are becoming increasingly more frustrated, with 56% feeling dissatisfied with their IT experience. Organizations looking to improve the dig
Biorasi Receives ISO 9001:2015 Certification for Quality Management11.5.2021 17:30:00 EEST | Press release
Biorasi, a leading global full-service contract research organization (CRO), is proud to announce the achievement of ISO 9001:2015 certification. By earning this ISO accreditation, Biorasi has demonstrated dedication to the practice of quality assurance within the clinical trials industry and commitment to quality excellence for individual clinical studies. “ISO 9001:2015 certification is a big deal for Biorasi,” said Chris O’Brien, CEO at Biorasi. “It is a powerful, independent validation of the quality of our processes. It sends a message to potential sponsors across the globe that Biorasi cares deeply about quality. It tells them they can trust us.” Biorasi was presented with their ISO 9001:2015 certification on May 5, 2021, joining the ranks of other quality-focused organizations, including our preferred vendor, IBM Watson Health. “Our Quality Policy is driven by the fundamental understanding that patients and their families are affected by the decisions we make,” said Todd Brill,
Alvotech Seeks to End AbbVie’s Wrongful Monopoly on Humira and Bring Affordable Arthritis Treatment to U.S.11.5.2021 17:23:00 EEST | Press release
Alvotech today filed a federal lawsuit (Case 1:21-cv-00589) seeking to end the monopoly that pharmaceutical giant AbbVie has long-maintained on the adalimumab market, sold as Humira. Humira is the highest grossing prescription drug in the United States with over $16 billion in sales in 2020 (nearly $20Bn globally). Alvotech has developed a biosimilar (analogous to a generic) of Humira called AVT02, the first-filed biosimilar drug equal in strength to Humira’s latest formulation, which AbbVie markets as a high-concentration, pain-free drug. The company is also developing AVT02 as an interchangeable product and it expects results from its ongoing interchangeability study in Q2 of this year. AVT02 could save U.S. taxpayers and the overall healthcare system $8-10 billion annually. “Our new product will be a gamechanger that will provide consumers who are suffering from chronic pain with significant savings, and we look forward to bringing this drug onto the market as soon as possible,” sai
The United Kingdom: Biolog-id and Nicholson Consulting Ltd Cooperate to Develop a Demonstration Lab to Showcase Biolog Transfusion Solution11.5.2021 16:01:00 EEST | Press release
Biolog-id, a global service provider of connected healthcare solutions, and Nicholson Consulting Ltd, an innovative consulting and engineering company specialized in the blood transfusion field, join their forces to set up a demonstration lab located at Malvern Hills Science Park, in the south of Birmingham. This co-branded demo environment will showcase to the UK market the biolog-id’s cutting-edge product-line: Biolog Transfusion Solution. Based on the RFID technology, Biolog Transfusion Solution has been designed to respond to the needs of all the actors involved along the blood transfusion supply chain. By combining software, equipment and tags, this breakthrough innovation offers to manage in real-time each application area, from collection and manufacturing at the blood centre, central and remote inventory at the blood banks to blood compound administration at patient’s bedside. Flexible and reliable, the biolog-id technology generates value throughout the lifecycle of blood prod
Kong Konnect Now Generally Available With Multi-Geo Support: Offers End Users Breakthrough API and Microservices Connectivity11.5.2021 16:00:00 EEST | Press release
Kong Inc., the cloud connectivity company, today announced the general availability release of Kong Konnect, a service connectivity platform that enables the modern connected business. First previewed at Kong Summit 2020 in private beta, Kong Konnect provides end users with instant access to a comprehensive suite of tools that enable reliable, secure and observable connectivity across their APIs and microservices. The GA release features new multi-geo support, allowing users to physically locate services close to their businesses for privacy and regulatory compliance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210511005311/en/ The fully modular platform enables developers, architects and operators to accelerate application development cycles and provide connectivity between services for stellar digital experiences. Architects decouple connectivity concerns from microservices so that developers can focus on building appli
MagBio Genomics Inc. Develops Automated RNA Purification Chemistry for Mawi iSWAB-RNA v2 on Thermofisher KingFisher™ Flex11.5.2021 16:00:00 EEST | Press release
Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces that MagBio Genomics has successfully developed an automated RNA purification method for iSWAB-RNA v2 on the Thermofisher KingFisher™ Flex platform with its HighPrep™ Total RNA Isolation Kit - iSWAB™. Mawi DNA Technologies’ iSWAB-RNA v2 allows for non-invasive self collection, concentration, and stabilization of intact buccal cells and/or any mammalian cells collected with a swab or cytobrush. It enables up to four weeks of real-time ambient stabilization of total RNA from the point of collection to processing. The high-quality RNA extracted from stabilized iSWAB-RNA v2 samples is suitable for gene expression applications such as real-time quantitative PCR, reverse transcription PCR, microarrays, northern blot analysis, nuclease protection assays, cDNA library construction and RNA-seq. “Collaborating with MagBio Genomics to optimize their HighPrep™ Total RNA
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom